Management of Chronic Hepatitis in Special Hosts and Special Situations: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Klimik Dergisi\/klimik Journal

• Publication date

  2015-03-30

• Fields of study

  Not labeled

• Identifiers
  DOI 10.5152/KD.2014.29
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues

  2014cited by this paper
• Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

  2014cited by this paper
• Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C

  2013cited by this paper
• Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality

  2013cited by this paper
• Treatment of patients with dual hepatitis B and C: a step in the right direction

  2013cited by this paper
• The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.

  2013cited by this paper
• Optimal management of HBV infection during pregnancy

  2013cited by this paper
• Prevention of recurrent hepatitis B infection after liver transplantation.

  2013influential reference
• Extrahepatic manifestations of acute hepatitis B virus infection.

  2013cited by this paper
• Epidemiology, Clinical Data, and Treatment of Viral Hepatitis in a Large Cohort of Intravenous Drug Users

  2013cited by this paper
• A rare case of acute hepatitis B virus infection causing guillain-barré syndrome.

  2013cited by this paper
• HCV and Host Lipids: An Intimate Connection

  2013cited by this paper
• High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review

  2013cited by this paper
• Metabolic Factors and Chronic Hepatitis C: A Complex Interplay

  2013cited by this paper
• Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C

  2013cited by this paper
• Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.

  2013cited by this paper
• Effects of Metabolic Syndrome on Fibrosis in Chronic Viral Hepatitis

  2013cited by this paper
• Tumor necrosis factor inhibitors for inflammatory bowel disease.

  2013cited by this paper
• Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses

  2013cited by this paper
• Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation

  2013cited by this paper
• Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact

  2012influential reference
• Impact of comorbidities on the severity of chronic hepatitis B at presentation.

  2012cited by this paper
• The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis

  2012cited by this paper
• Management of hepatitis C in HIV and/or HBV co-infected patients.

  2012cited by this paper
• Utilization of hepatitis B core antibody-positive donor liver grafts.

  2012cited by this paper
• The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan

  2012cited by this paper
• APASL consensus statements and management algorithms for hepatitis C virus infection

  2012cited by this paper
• Acute‐on‐chronic liver failure in chronic hepatitis B

  2012cited by this paper
• Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?

  2012cited by this paper
• Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function.

  2012cited by this paper
• Management of hepatitis B reactivation in patients receiving cancer chemotherapy

  2012cited by this paper
• Boceprevir for untreated chronic HCV genotype 1 infection.

  2011cited by this paper
• Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.

  2011cited by this paper
• HBV treatment and pregnancy.

  2011cited by this paper
• Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B.

  2011cited by this paper
• Hepatitis B, C and D coinfection in HIV-infected patients: prevalence and progress.

  2011cited by this paper
• Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.

  2011cited by this paper
• Virus de l’hépatite B, manifestations extrahépatiques immunologiques et risque de réactivation virale

  2011cited by this paper
• Management of Hepatic Encephalopathy

  2011cited by this paper
• A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.

  2011cited by this paper
• Interpretation:An update on treatment of genotype 1 chronic hepatitis C virus infection:2011 practice guideline by the American Association for the Study of Liver Diseases

  2011cited by this paper
• An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases

  2011cited by this paper
• Liver transplant and chronic hepatitis B virus infection.

  2011influential reference
• Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).

  2011influential reference
• Should Ribavirin Be Used to Treat Hepatitis C in Dialysis Patients?

  2011cited by this paper
• Telaprevir for previously untreated chronic hepatitis C virus infection.

  2011cited by this paper
• Antiviral Therapy for Hepatitis B Infection during Pregnancy and Breastfeeding

  2011cited by this paper
• A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.

  2011cited by this paper
• EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

  2011cited by this paper
• Viral hepatitis and HIV co-infection.

  2010cited by this paper
• British HIV Association guidelines for the management of coinfection with HIV‐1 and hepatitis B or C virus 2010

  2010cited by this paper
• Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.

  2010cited by this paper
• The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.

  2010cited by this paper
• Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

  2010cited by this paper
• Pregnancy and chronic hepatitis B virus infection

  2010cited by this paper
• Management of patients coinfected with HBV and HCV

  2010cited by this paper
• Breastfeeding and chronic HBV infection: clinical and social implications.

  2010cited by this paper
• Treatment of extrahepatic manifestations of chronic hepatitis C viral infection--a challenge.

  2010cited by this paper
• Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.

  2010cited by this paper
• Complementary and Alternative Medicine Use in Chronic Liver Disease Patients

  2010cited by this paper
• Entecavir treatment for chronic hepatitis B infection in end-stage renal disease and kidney transplantation

  2010cited by this paper
• Systematic review: anti‐viral therapy of recurrent hepatitis C after liver transplantation

  2010cited by this paper
• HIV/hepatitis B virus co-infection: current challenges and new strategies.

  2010cited by this paper
• Safety of ribavirin in adolescent thalassemic patients with chronic hepatitis C virus infection.

  2010cited by this paper
• Management of chronic hepatitis B in pregnancy.

  2010cited by this paper
• Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

  2010cited by this paper
• Impact of alcohol on hepatitis C virus replication and interferon signaling.

  2010cited by this paper
• [Hepatitis B and pregnancy].

  2009cited by this paper
• Climate change and human health: recognising the really inconvenient truth

  2009cited by this paper
• Viral Interference Between Hepatitis B, C, and D Viruses in Dual and Triple Infections in HIV-Positive Patients

  2009cited by this paper
• Hepatitis B and pregnancy: an underestimated issue

  2009cited by this paper
• Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)

  2009cited by this paper
• Management of hepatitis B in pregnancy: Weighing the options

  2009cited by this paper
• Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study

  2009cited by this paper
• Diagnosis, management, and treatment of hepatitis C: An update

  2009cited by this paper
• Mortality among opiate users: opioid maintenance therapy, age and causes of death.

  2009cited by this paper
• Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

  2009cited by this paper
• Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

  2009cited by this paper
• Outcomes of a patient‐to‐patient outbreak of genotype 3a hepatitis C

  2009cited by this paper
• Management of viral hepatitis in hematologic malignancies.

  2008cited by this paper
• Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.

  2008cited by this paper
• Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

  2008cited by this paper
• Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

  2008cited by this paper
• Triple hepatitis: frequency and treatment outcome of co/super-infection of hepatitis C and D among patients of hepatitis B.

  2008cited by this paper
• Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

  2008cited by this paper
• The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.

  2008cited by this paper
• Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy

  2008cited by this paper
• The extrahepatic manifestations of hepatitis B virus.

  2008cited by this paper
• [HIV and hepatitis C coinfection].

  2008cited by this paper
• Abacavir does not Influence the Rate of Virological Response in HIV–HCV-Coinfected Patients Treated with Pegylated Interferon and Weight-Adjusted Ribavirin

  2008cited by this paper
• Low Response to Pegylated Interferon plus Ribavirin in HIV-Infected Patients with Chronic Hepatitis C Treated with Abacavir

  2008cited by this paper
• Lamivudine treatment for severe acute HBV hepatitis

  2008cited by this paper
• Multiple viral hepatitis in injection drug users and associated risk factors

  2007cited by this paper
• Exacerbation of chronic hepatitis B infection after delivery

  2007cited by this paper
• Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies

  2007cited by this paper
• Interferon monotherapy of chronic hepatitis C in dialysis patients: meta‐analysis of clinical trials

  2007cited by this paper
• The HBV drug entecavir - effects on HIV-1 replication and resistance.

  2007cited by this paper
• Psychiatric comorbidity and gender difference among treatment‐seeking heroin abusers in Taiwan

  2007cited by this paper
• Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?

  2007cited by this paper
• Predictors of Severe Haematological Toxicity Secondary to Pegylated Interferon plus Ribavirin Treatment in HIV-HCV-Coinfected Patients

  2007cited by this paper

• No citing papers are available for this paper.